Pei‐Lun Lee

发表

A higher than expected recovery rate from hepatitis C infection amongst adolescents: a community study in a hepatitis C-endemic township in Taiwan.

Sheng-Nan Lu, Chuan‐Mo Lee, Jing-Houng Wang, 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Serum hepatitis B surface antigen level might predict cirrhosis and hepatocellular carcinoma in older patients with chronic hepatitis B

Jyh-Jou Chen, Pei‐Lun Lee, H. Tung, 2015 .

Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan

Mei-Hsuan Lee, J. Kao, Chun-Jen Liu, 2021, Infectious Diseases and Therapy.

Real‐world effectiveness and safety of ledipasvir/sofosbuvir for genotype 6 chronic hepatitis C patients in Taiwan

Jyh-Jou Chen, P. Cheng, Yen-Cheng Chiu, 2020, Journal of gastroenterology and hepatology.

The economic burden of childhood invasive pneumococcal diseases and pneumonia in Taiwan: Implications for a pneumococcal vaccination program

Kow-Tong Chen, Yu-Chiao Wang, Pei‐Lun Lee, 2015, Human vaccines & immunotherapeutics.

Factors Associated with Significant Platelet Count Improvement in Thrombocytopenic Chronic Hepatitis C Patients Receiving Direct-Acting Antivirals

J. Kao, Chia-Chi Wang, Han‐Chieh Lin, 2022, Viruses.

Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan

J. Kao, Chun-Jen Liu, C. Hung, 2021, Hepatology International.

Itemization difference of patient-reported outcome in patients with chronic liver disease

Ming‐Lung Yu, M. Yeh, Chung‐Feng Huang, 2022, PloS one.

Lipid profile changes after direct acting antiviral treatment in different genotypes of chronic hepatitis C virus‐infected patients

Jyh-Jou Chen, Pei‐Lun Lee, H. Tung, 2020 .

Bile Duct Stone Size May Influence the Efficacy of Endoscopic Sphincterotomy With or Without Large-Balloon Dilation: A Meta-Analysis.

Jyh-Jou Chen, Jyu-Lin Chen, Pei‐Lun Lee, 2022, Journal of laparoendoscopic & advanced surgical techniques. Part A.

Metformin reduces hepatocellular carcinoma incidence after successful antiviral therapy in patients with diabetes and chronic hepatitis C in Taiwan.

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2022, Journal of hepatology.

Hepatitis B virus infection in adolescents in a rural township--15 years subsequent to mass hepatitis B vaccination in Taiwan.

Sheng-Nan Lu, Chien-Hung Chen, C. Changchien, 2006, Vaccine.

The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon‐alpha and ribavirin combination therapy

M. Hsieh, C. Dai, J-F Huang, 2006, Journal of viral hepatitis.

Hepatitis C Virus Subtypes Novel 6g-Related Subtype and 6w Could Be Indigenous in Southern Taiwan with Characteristic Geographic Distribution

H. Kuo, Jyh-Jou Chen, M. Sheu, 2021, Viruses.

Geographic variation of genotype 6 hepatitis C virus infection in an endemic area of southern Taiwan.

H. Kuo, Jyh-Jou Chen, M. Sheu, 2020, Journal of the Formosan Medical Association = Taiwan yi zhi.

High prevalence of genotype 6 hepatitis C virus infection in Southern Taiwan using Abbott genotype assays.

H. Kuo, Jyh-Jou Chen, M. Sheu, 2019, Journal of the Formosan Medical Association = Taiwan yi zhi.

Fundic gland polyps is more common in patients with relative healthy gastric mucosa

Jyh-Jou Chen, Pei‐Lun Lee, H. Tung, 2018, Advances in Digestive Medicine.

Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

J. Kao, Chun-Jen Liu, Chun-Chao Chang, 2021, Gut.

Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis

J. Kao, Chun-Jen Liu, Chun-Chao Chang, 2021, Clinical and molecular hepatology.

Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Hepatology International.

Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, The American journal of gastroenterology.

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Influenza vaccination coverage and factors affecting adherence to influenza vaccination among patients with diabetes in Taiwan

Kow-Tong Chen, Pei‐Lun Lee, Yi-Ching Yang, 2014, Human vaccines & immunotherapeutics.

Idiopathic mesenteric phlebosclerosis caused by traditional medicine in a married couple and review of literature

Jyh-Jou Chen, Ming‐Jenn Chen, Pei‐Lun Lee, 2018, Advances in Digestive Medicine.

Real-world effectiveness and safety of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for genotype 6 chronic hepatitis C.

Jyh-Jou Chen, P. Cheng, Yen-Cheng Chiu, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis‐related complications (Taiwanese chronic hepatitis C cohort)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Scientific Reports.

Impact of sofosbuvir-based direct-acting antivirals on renal function in chronic hepatitis C patients with impaired renal function: a large cohort study from the nationwide HCV Registry Program (TACR).

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Long‐term risk of end‐stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2021, Journal of gastroenterology and hepatology.

An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution.

J. Kao, Jyh-Jou Chen, Yi‐Hsiang Huang, 2019, The Journal of infectious diseases.

Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH)

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2020, Open forum infectious diseases.

Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan.

J. Kao, Chun-Jen Liu, Chia-Chi Wang, 2022, Journal of the Formosan Medical Association = Taiwan yi zhi.

Association between cryoglobulinemia and liver fibrosis in chronic hepatitis C patients

M. Yeh, Chung‐Feng Huang, C. Dai, 2018, Journal of gastroenterology and hepatology.

Sofosbuvir/velpatasvir/voxilaprevir for patients with chronic hepatitis C virus infection previously treated with NS5A direct-acting antivirals: a real-world multicenter cohort in Taiwan

J. Kao, Chun-Jen Liu, Y. Shih, 2023, Hepatology International.

Body weight increase and metabolic derangements after tenofovir disoproxil fumarate switch to tenofovir alafenamide in patients with chronic hepatitis B.

H. Kuo, Jyh-Jou Chen, P. Cheng, 2023, Alimentary pharmacology & therapeutics.

Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate

Chia-Yi Hou, Pei‐Lun Lee, I. Feng, 2023, Life.